Acor­da files for bank­rupt­cy, agrees to sell MS drug and oth­er as­sets to Merz for $185M

Acor­da Ther­a­peu­tics’ stock tanked Tues­day af­ter an­nounc­ing Chap­ter 11 bank­rupt­cy and the sale of its as­sets to Merz Ther­a­peu­tics for $185 mil­lion.

The once high …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER